Evidence map›Paper›PMID 32596126›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Selenium-Doped Carbon Quantum Dots Act as Broad-Spectrum Antioxidants for Acute Kidney Injury Management.

Zachary T Rosenkrans, Tuanwei Sun, Dawei Jiang, Weiyu Chen, Todd E Barnhart, Ziyi Zhang, Carolina A Ferreira, Xudong Wang, Jonathan W Engle, Peng Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 205 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Zachary T RosenkransDepartment of Pharmaceutical Sciences University of Wisconsin-Madison Madison WI 53705 USA.
Tuanwei SunMarshall Laboratory of Biomedical Engineering International Cancer Center Laboratory of Evolutionary Theranostics School of Biomedical Engineering Shenzhen University Health Science Center Shenzhen 518060 China.
Dawei JiangMarshall Laboratory of Biomedical Engineering International Cancer Center Laboratory of Evolutionary Theranostics School of Biomedical Engineering Shenzhen University Health Science Center Shenzhen 518060 China.ORCID https://orcid.org/0000-0002-4072-0075
Weiyu ChenDepartments of Radiology and Medical Physics University of Wisconsin-Madison Madison WI 53705 USA.
Todd E BarnhartDepartments of Radiology and Medical Physics University of Wisconsin-Madison Madison WI 53705 USA.
Ziyi ZhangDepartment of Materials Science and Engineering University of Wisconsin-Madison Madison WI 53705 USA.
Carolina A FerreiraDepartments of Radiology and Medical Physics University of Wisconsin-Madison Madison WI 53705 USA.
Xudong WangDepartment of Materials Science and Engineering University of Wisconsin-Madison Madison WI 53705 USA.
Jonathan W EngleDepartments of Radiology and Medical Physics University of Wisconsin-Madison Madison WI 53705 USA.
Peng HuangMarshall Laboratory of Biomedical Engineering International Cancer Center Laboratory of Evolutionary Theranostics School of Biomedical Engineering Shenzhen University Health Science Center Shenzhen 518060 China.
Weibo CaiDepartment of Pharmaceutical Sciences University of Wisconsin-Madison Madison WI 53705 USA.ORCID https://orcid.org/0000-0003-4641-0833
University of Wisconsin–Madison · USShenzhen University Health Science Center · CN

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
NCI NIH HHS P30 CA014520
6 · The paper itself

Abstract

The manifestation of acute kidney injury (AKI) is associated with poor patient outcomes, with treatment options limited to hydration or renal replacement therapies. The onset of AKI is often associated with a surfeit of reactive oxygen species. Here, it is shown that selenium-doped carbon quantum dots (SeCQDs) have broad-spectrum antioxidant properties and prominent renal accumulation in both healthy and AKI mice. Due to these properties, SeCQDs treat or prevent two clinically relevant cases of AKI induced in murine models by either rhabdomyolysis or cisplatin using only 1 or 50 µg per mouse, respectively. The attenuation of AKI in both models is confirmed by blood serum measurements, kidney tissue staining, and relevant biomarkers. The therapeutic efficacy of SeCQDs exceeds amifostine, a drug approved by the Food and Drug Administration that also acts by scavenging free radicals. The findings indicate that SeCQDs show great potential as a treatment option for AKI and possibly other ROS-related diseases.

Indexed as

acute kidney injurycarbon quantum dotscisplatinnanomedicinepositron emission tomographyrhabdomyolysisselenium

Identifiers

PMID32596126
PMCPMC7312409
OpenAlexW3021730921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.